ZIDOVUDINE Side Effects

7022831-4 | Neutropenia
on Sep 29, 2010 Male patient from UGANDA , child 5 years of age, was diagnosed with malaria prophylaxis and was treated with Zidovudine (View Usage). Patient experienced the following unwanted or unexpected effects: neutropenia. Zidovudine dosage: . During the same period patient was treated with LAMIVUDINE HIV (View Lamivudine-hiv Review and Lamivudine-hiv Label ), BACTRIM (View Bactrim Review and Bactrim Label ), LOPINAVIR/RITONAVIR (View Lopinavir/ritonavir Review and Lopinavir/ritonavir Label ), ARTEMETHER + LUMEFANTRINE (View Artemether + Lumefantrine Review and Artemether + Lumefantrine Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ).

7015367-8 | Hyperlipidaemia, Immune Reconstitution Syndrome, Tuberculosis
Patient was taking Zidovudine (View Usage). Patient had the following side effects: hyperlipidaemia, immune reconstitution syndrome, tuberculosis (What is tuberculosis?) on Sep 20, 2010 from Additional patient health information: Male patient , 53 years of age, was diagnosed with hiv infection (What is hiv infection?), diffuse large b-cell lymphoma and. Zidovudine dosage: . During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), HYDROXYDAUNORUBICIN (View Hydroxydaunorubicin Review and Hydroxydaunorubicin Label ), ONCOVIN (View Oncovin Review and Oncovin Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), COTRIMAXAZOLE (View Cotrimaxazole Review and Cotrimaxazole Label ). Patient was hospitalized.

7007138-3 | Blood Lactate Dehydrogenase Increased, Hepatosplenomegaly, Immune Reconstitution Syndrome, Lymphadenopathy, Oral Candidiasis, Tuberculosis
Adverse event was reported on Aug 24, 2010 by a Male patient taking Zidovudine (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?), b-cell lymphoma and. Location: INDIA , 53 years of age, After Zidovudine was administered, patient had the following side effects: blood lactate dehydrogenase increased, hepatosplenomegaly, immune reconstitution syndrome, lymphadenopathy, oral candidiasis, tuberculosis (What is tuberculosis?). During the same period patient was treated with LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), COTRIM (View Cotrim Review and Cotrim Label ). Patient was hospitalized.

6985479-3 | Aortic Valve Sclerosis, Apnoea, Caesarean Section, Cardiac Arrest, Cardiac Murmur, Congenital Heart Valve Disorder, Congenital Pulmonary Valve Disorder, Large For Dates Baby
on Sep 13, 2010 Female patient from UNITED KINGDOM , weighting 7.52 lb, was diagnosed with antiviral treatment, hiv infection (What is hiv infection?) and was treated with Zidovudine (View Usage). Patient experienced the following unwanted or unexpected effects: aortic valve sclerosis, apnoea, caesarean section, cardiac arrest (What is cardiac arrest?), cardiac murmur, congenital heart valve disorder, congenital pulmonary valve disorder, large for dates baby. Zidovudine dosage: . During the same period patient was treated with ISENTRESS (800mg Per Day) (View Isentress Review and Isentress Label ), TRUVADA (View Truvada Review and Truvada Label ), NORVIR (View Norvir Review and Norvir Label ), PREZISTA (1200mg Per Day) (View Prezista Review and Prezista Label ).


6956579-9 | Aortic Valve Disease, Caesarean Section, Cardiac Murmur, Congenital Pulmonary Valve Disorder, Dysplasia, Neonatal Respiratory Arrest, Ventricular Hypertrophy
on Aug 12, 2010 Female patient from , weighting 7.52 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Zidovudine (View Usage). Patient had the following side effects: aortic valve disease, caesarean section, cardiac murmur, congenital pulmonary valve disorder, dysplasia, neonatal respiratory arrest, ventricular hypertrophy. Zidovudine dosage: Transplacental. During the same period patient was treated with DARUNAVIR ETHANOLATE (600mg, Bid, Transplacent) (View Darunavir Ethanolate Review and Darunavir Ethanolate Label ), ISENTRESS (400mg, Bid, Transplacental) (View Isentress Review and Isentress Label ), RITONAVIR (Transplacental) (View Ritonavir Review and Ritonavir Label ), TRUVADA (Transplacental) (View Truvada Review and Truvada Label ).

6946314-2 | Cardiac Murmur, Hyperbilirubinaemia Neonatal
Patient was taking Zidovudine (View Usage). After Zidovudine was administered, patient had the following side effects: cardiac murmur, hyperbilirubinaemia neonatal on Jul 16, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 6.31 lb, was diagnosed with acquired immunodeficiency syndrome and. Zidovudine dosage: Oral. During the same period patient was treated with DARUNAVIR (View Darunavir Review and Darunavir Label ), LAMIVUDINE + ZIDOVUDINE (View Lamivudine + Zidovudine Review and Lamivudine + Zidovudine Label ).

6945777-6 | Apnoea, Cardiac Arrest, Cardiac Murmur, Congenital Heart Valve Disorder, Ventricular Hypertrophy
Adverse event was reported on Aug 23, 2010 by a Female patient taking Zidovudine (View Usage) (Dosage: ) . Location: UNITED KINGDOM , child 1 years of age, weighting 7.52 lb, Patient experienced the following unwanted or unexpected effects: apnoea, cardiac arrest (What is cardiac arrest?), cardiac murmur, congenital heart valve disorder, ventricular hypertrophy. During the same period patient was treated with NORVIR (View Norvir Review and Norvir Label ), RALTEGRAVIR (View Raltegravir Review and Raltegravir Label ), PREZISTA (View Prezista Review and Prezista Label ).

6945767-3 | Aortic Valve Disease, Aortic Valve Sclerosis, Apnoea, Cardiac Arrest, Cardiac Murmur, Congenital Heart Valve Disorder, Congenital Pulmonary Valve Disorder, Large For Dates Baby
on Aug 23, 2010 Female patient from UNITED KINGDOM , weighting 7.52 lb, was diagnosed with antiviral treatment and was treated with Zidovudine (View Usage). Patient had the following side effects: aortic valve disease, aortic valve sclerosis, apnoea, cardiac arrest (What is cardiac arrest?), cardiac murmur, congenital heart valve disorder, congenital pulmonary valve disorder, large for dates baby. Zidovudine dosage: . During the same period patient was treated with RITONAVIR (View Ritonavir Review and Ritonavir Label ), ISENTRESS (800mg Per Day) (View Isentress Review and Isentress Label ), DARUNAVIR ETHANOLATE (1200mg Per Day) (View Darunavir Ethanolate Review and Darunavir Ethanolate Label ), TRUVADA (View Truvada Review and Truvada Label ).

6943914-0 | Hepatic Enzyme Increased, Treatment Noncompliance
on Aug 24, 2010 Male patient from MALAWI , weighting 22.49 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Zidovudine (View Usage). After Zidovudine was administered, patient had the following side effects: hepatic enzyme increased, treatment noncompliance. Zidovudine dosage: 10ml Twice Per Day. During the same period patient was treated with LAMIVUDINE (4ml Twice Per Day) (View Lamivudine Review and Lamivudine Label ), NEVIRAPINE (10ml Per Day) (View Nevirapine Review and Nevirapine Label ), COTRIM (View Cotrim Review and Cotrim Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ).

6941021-4 | Apnoea, Cardiac Arrest, Cardiac Murmur, Congenital Heart Valve Disorder, Ventricular Hypertrophy
Patient was taking Zidovudine (View Usage). Patient experienced the following unwanted or unexpected effects: apnoea, cardiac arrest (What is cardiac arrest?), cardiac murmur, congenital heart valve disorder, ventricular hypertrophy on Aug 17, 2010 from UNITED KINGDOM Additional patient health information: Female patient , child 1 years of age, weighting 7.52 lb, . Zidovudine dosage: . During the same period patient was treated with NORVIR (View Norvir Review and Norvir Label ), RALTEGRAVIR (View Raltegravir Review and Raltegravir Label ), PREZISTA (View Prezista Review and Prezista Label ).

6939469-7 | Aortic Valve Disease, Apnoea, Cardiac Murmur, Congenital Aortic Stenosis, Pulmonary Artery Stenosis Congenital, Ventricular Hypertrophy
Adverse event was reported on Aug 04, 2010 by a Female patient taking Zidovudine (View Usage) (Dosage: Transplacental) . Location: , weighting 7.52 lb, Patient had the following side effects: aortic valve disease, apnoea, cardiac murmur, congenital aortic stenosis, pulmonary artery stenosis congenital, ventricular hypertrophy. During the same period patient was treated with RITONAVIR (Transplacental) (View Ritonavir Review and Ritonavir Label ), RALTEGRAVIR (800mg, Qd, Transplacental) (View Raltegravir Review and Raltegravir Label ), DARUNAVIR ETHANOLATE (1200mg, Qd, Transplacental) (View Darunavir Ethanolate Review and Darunavir Ethanolate Label ).

6930553-0 | Aortic Valve Disease, Aortic Valve Sclerosis, Apnoea, Cardiac Arrest, Cardiac Murmur, Congenital Heart Valve Disorder, Congenital Pulmonary Valve Disorder, Large For Dates Baby
on Aug 10, 2010 Female patient from UNITED KINGDOM , weighting 7.52 lb, was diagnosed with antiviral treatment and was treated with Zidovudine (View Usage). After Zidovudine was administered, patient had the following side effects: aortic valve disease, aortic valve sclerosis, apnoea, cardiac arrest (What is cardiac arrest?), cardiac murmur, congenital heart valve disorder, congenital pulmonary valve disorder, large for dates baby. Zidovudine dosage: . During the same period patient was treated with RITONAVIR (View Ritonavir Review and Ritonavir Label ), ISENTRESS (800mg Per Day) (View Isentress Review and Isentress Label ), DARUNAVIR (1200mg Per Day) (View Darunavir Review and Darunavir Label ), TRUVADA (View Truvada Review and Truvada Label ).

6929270-2 | Aortic Valve Disease, Caesarean Section, Cardiac Murmur, Neonatal Respiratory Arrest, Pulmonary Valve Disease, Ventricular Hypertrophy
on Jul 29, 2010 Female patient from , weighting 7.52 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Zidovudine (View Usage). Patient experienced the following unwanted or unexpected effects: aortic valve disease, caesarean section, cardiac murmur, neonatal respiratory arrest, pulmonary valve disease, ventricular hypertrophy. Zidovudine dosage: Transplacental. During the same period patient was treated with DARUNAVIR ETHANOLATE (600 Mg, Bid, Transplacent) (View Darunavir Ethanolate Review and Darunavir Ethanolate Label ), ISENTRESS (400 Mg, Bid, Transplacental) (View Isentress Review and Isentress Label ), RITONAVIR (Transplacental) (View Ritonavir Review and Ritonavir Label ), TRUVADA (Transplacental) (View Truvada Review and Truvada Label ).

6928473-0 | Caesarean Section, Cardiac Arrest Neonatal, Cardiac Murmur, Congenital Heart Valve Disorder, Congenital Pulmonary Valve Disorder, Infantile Apnoeic Attack, Ventricular Hypertrophy
Patient was taking Zidovudine (View Usage). Patient had the following side effects: caesarean section, cardiac arrest neonatal, cardiac murmur, congenital heart valve disorder, congenital pulmonary valve disorder, infantile apnoeic attack, ventricular hypertrophy on Jul 28, 2010 from Additional patient health information: Female patient , weighting 7.52 lb, . Zidovudine dosage: Transplacental. During the same period patient was treated with RITONAVIR (Transplacental) (View Ritonavir Review and Ritonavir Label ), RALTEGRAVIR (800mg, Qd, Transplacental) (View Raltegravir Review and Raltegravir Label ), DARUNAVIR (1200mg, Qd, Transplacental) (View Darunavir Review and Darunavir Label ).

6925787-5 | Neutropenia
Adverse event was reported on Aug 11, 2010 by a Male patient taking Zidovudine (View Usage) (Dosage: ) was diagnosed with malaria prophylaxis and. Location: UGANDA , child 5 years of age, After Zidovudine was administered, patient had the following side effects: neutropenia. During the same period patient was treated with LAMIVUDINE HIV (View Lamivudine-hiv Review and Lamivudine-hiv Label ), BACTRIM (View Bactrim Review and Bactrim Label ), LOPINAVIR/RITONAVIR (View Lopinavir/ritonavir Review and Lopinavir/ritonavir Label ), ARTEMETHER + LUMEFANTRINE (View Artemether + Lumefantrine Review and Artemether + Lumefantrine Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ).

6925120-9 | Asthenia, Decreased Appetite, Hepatomegaly, Hepatotoxicity, Nausea, Nephrolithiasis
on Aug 02, 2010 Female patient from ITALY , 43 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Zidovudine (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, decreased appetite, hepatomegaly, hepatotoxicity, nausea (What is nausea?), nephrolithiasis. Zidovudine dosage: . During the same period patient was treated with LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), INDINAVIR (View Indinavir Review and Indinavir Label ), SAQUINAVIR (View Saquinavir Review and Saquinavir Label ), DIDANOSINE (View Didanosine Review and Didanosine Label ), STAVUDINE (View Stavudine Review and Stavudine Label ), NEVIRAPINE (View Nevirapine Review and Nevirapine Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), ABACAVIR SULPHATE (View Abacavir Sulphate Review and Abacavir Sulphate Label ). Patient was hospitalized.

6914244-8 | Aortic Valve Disease, Apnoea, Cardiac Murmur, Congenital Heart Valve Disorder, Congenital Pulmonary Valve Disorder, Ventricular Hypertrophy
on Aug 05, 2010 Female patient from UNITED KINGDOM , weighting 7.50 lb, was treated with Zidovudine (View Usage). Patient had the following side effects: aortic valve disease, apnoea, cardiac murmur, congenital heart valve disorder, congenital pulmonary valve disorder, ventricular hypertrophy. Zidovudine dosage: . During the same period patient was treated with PREZISTA (1200mgd Per Day) (View Prezista Review and Prezista Label ), ISENTRESS (800mgd Per Day) (View Isentress Review and Isentress Label ), NORVIR (View Norvir Review and Norvir Label ).

6909253-9 | Cardiac Murmur, Congenital Anomaly, Hyperbilirubinaemia Neonatal
Patient was taking Zidovudine (View Usage). After Zidovudine was administered, patient had the following side effects: cardiac murmur, congenital anomaly, hyperbilirubinaemia neonatal on Jul 16, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 6.31 lb, was diagnosed with acquired immunodeficiency syndrome and. Zidovudine dosage: Oral. During the same period patient was treated with DARUNAVIR (View Darunavir Review and Darunavir Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), LAMIVUDINE + ZIDOVUDINE (View Lamivudine + Zidovudine Review and Lamivudine + Zidovudine Label ).

6908770-5 | Aortic Valve Disease, Apnoea, Cardiac Murmur, Congenital Heart Valve Disorder, Congenital Pulmonary Valve Disorder, Ventricular Hypertrophy
Adverse event was reported on Aug 05, 2010 by a Female patient taking Zidovudine (View Usage) (Dosage: ) . Location: UNITED KINGDOM , weighting 7.50 lb, Patient experienced the following unwanted or unexpected effects: aortic valve disease, apnoea, cardiac murmur, congenital heart valve disorder, congenital pulmonary valve disorder, ventricular hypertrophy. During the same period patient was treated with PREZISTA (1200mgd Per Day) (View Prezista Review and Prezista Label ), ISENTRESS (800mgd Per Day) (View Isentress Review and Isentress Label ), NORVIR (View Norvir Review and Norvir Label ).

6907232-9 | Caesarean Section, Congenital Heart Valve Disorder, Infantile Apnoeic Attack, Ventricular Hypertrophy
on Jul 16, 2010 Female patient from , weighting 7.52 lb, was treated with Zidovudine (View Usage). Patient had the following side effects: caesarean section, congenital heart valve disorder, infantile apnoeic attack, ventricular hypertrophy. Zidovudine dosage: Transplacental. During the same period patient was treated with RITONAVIR (Transplacental) (View Ritonavir Review and Ritonavir Label ), RALTEGRAVIR (800mg, Qd, Transplacental) (View Raltegravir Review and Raltegravir Label ), DARUNAVIR (1200mg, Qd, Transplacental) (View Darunavir Review and Darunavir Label ).

6905346-0 | Congenital Anomaly In Offspring, Pregnancy
on Jul 15, 2010 Female patient from UNITED STATES , 20 years of age, was diagnosed with antiviral treatment and was treated with Zidovudine (View Usage). After Zidovudine was administered, patient had the following side effects: congenital anomaly in offspring, pregnancy (What is pregnancy?). Zidovudine dosage: . During the same period patient was treated with PREZISTA (800 Mg Daily, Oral; 1200 Mg Daily, Oral; 12 Mg Daily, Oral) (View Prezista Review and Prezista Label ), NORVIR (100 Mg, Daily, Oral; 200 Mg Daily, Oral; 200 Mg Daily, Oral) (View Norvir Review and Norvir Label ), COMBIVIR (View Combivir Review and Combivir Label ).

6896195-0 | Aortic Valve Disease, Apnoea, Cardiac Murmur, Congenital Heart Valve Disorder, Congenital Pulmonary Valve Disorder, Ventricular Hypertrophy
Patient was taking Zidovudine (View Usage). Patient experienced the following unwanted or unexpected effects: aortic valve disease, apnoea, cardiac murmur, congenital heart valve disorder, congenital pulmonary valve disorder, ventricular hypertrophy on Jul 29, 2010 from UNITED KINGDOM Additional patient health information: Female patient , weighting 7.50 lb, . Zidovudine dosage: . During the same period patient was treated with PREZISTA (1200mgd Per Day) (View Prezista Review and Prezista Label ), ISENTRESS (800mgd Per Day) (View Isentress Review and Isentress Label ), NORVIR (View Norvir Review and Norvir Label ).

6893726-1 |
Adverse event was reported on Mar 26, 2010 by a Male patient taking Zidovudine (View Usage) (Dosage: Unk) was diagnosed with antiviral prophylaxis, hiv infection (What is hiv infection?) and. Location: UNITED KINGDOM , weighting 7.05 lb, . During the same period patient was treated with LAMIVUDINE (Unk) (View Lamivudine Review and Lamivudine Label ), NEVIRAPINE (Unk) (View Nevirapine Review and Nevirapine Label ), COMBIVIR (Unk) (View Combivir Review and Combivir Label ), KALETRA (Unk) (View Kaletra Review and Kaletra Label ), SEPTRIN (Unk) (View Septrin Review and Septrin Label ).

6880514-5 | Aortic Valve Disease, Apnoea, Cardiac Murmur, Congenital Heart Valve Disorder, Congenital Pulmonary Valve Disorder, Ventricular Hypertrophy
on Jul 21, 2010 Female patient from UNITED KINGDOM , weighting 7.52 lb, was diagnosed with antiviral treatment and was treated with Zidovudine (View Usage). After Zidovudine was administered, patient had the following side effects: aortic valve disease, apnoea, cardiac murmur, congenital heart valve disorder, congenital pulmonary valve disorder, ventricular hypertrophy. Zidovudine dosage: . During the same period patient was treated with RITONAVIR (View Ritonavir Review and Ritonavir Label ), ISENTRESS (800mg Per Day) (View Isentress Review and Isentress Label ), DARUNAVIR (1200mg Per Day) (View Darunavir Review and Darunavir Label ), TRUVADA (View Truvada Review and Truvada Label ).

6876249-5 | Apnoea, Cardiac Arrest, Cardiac Murmur, Congenital Heart Valve Disorder, Ventricular Hypertrophy
on Jul 16, 2010 Female patient from UNITED KINGDOM , weighting 7.50 lb, was treated with Zidovudine (View Usage). Patient experienced the following unwanted or unexpected effects: apnoea, cardiac arrest (What is cardiac arrest?), cardiac murmur, congenital heart valve disorder, ventricular hypertrophy. Zidovudine dosage: . During the same period patient was treated with PREZISTA (1200mgd Per Day) (View Prezista Review and Prezista Label ), ISENTRESS (800mgd Per Day) (View Isentress Review and Isentress Label ), NORVIR (View Norvir Review and Norvir Label ).

6871115-3 | Immune Reconstitution Syndrome, Visceral Leishmaniasis
Patient was taking Zidovudine (View Usage). Patient had the following side effects: immune reconstitution syndrome, visceral leishmaniasis on Jul 09, 2010 from AUSTRALIA Additional patient health information: Male patient , 60 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Zidovudine dosage: . During the same period patient was treated with LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), LOPINAVIR/RITONAVIR (View Lopinavir/ritonavir Review and Lopinavir/ritonavir Label ), TENOFOVIR DISOPROXIL FUMARATE (View Tenofovir Disoproxil Fumarate Review and Tenofovir Disoproxil Fumarate Label ), COTRIM (View Cotrim Review and Cotrim Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), ABACAVIR (View Abacavir Review and Abacavir Label ).

6848183-8 | Aortic Valve Disease, Apnoea, Cardiac Murmur, Congenital Heart Valve Disorder, Congenital Pulmonary Valve Disorder, Ventricular Hypertrophy
Adverse event was reported on Jul 14, 2010 by a Female patient taking Zidovudine (View Usage) (Dosage: ) was diagnosed with antiviral treatment and. Location: UNITED KINGDOM , weighting 7.52 lb, After Zidovudine was administered, patient had the following side effects: aortic valve disease, apnoea, cardiac murmur, congenital heart valve disorder, congenital pulmonary valve disorder, ventricular hypertrophy. During the same period patient was treated with RITONAVIR (View Ritonavir Review and Ritonavir Label ), ISENTRESS (800mg Per Day) (View Isentress Review and Isentress Label ), DARUNAVIR (1200mg Per Day) (View Darunavir Review and Darunavir Label ), TRUVADA (View Truvada Review and Truvada Label ).

6826307-6 | Adrenal Insufficiency, Hypotension, Immune Reconstitution Syndrome, Pulmonary Tuberculosis, Respiratory Failure
on Jul 06, 2010 Male patient from , 47 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Zidovudine (View Usage). Patient experienced the following unwanted or unexpected effects: adrenal insufficiency, hypotension, immune reconstitution syndrome, pulmonary tuberculosis, respiratory failure. Zidovudine dosage: . During the same period patient was treated with EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ). Patient was hospitalized.

6814058-3 | Basedow's Disease, Lobar Pneumonia
on Jun 30, 2010 Male patient from , child 11 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Zidovudine (View Usage). Patient had the following side effects: basedow's disease, lobar pneumonia. Zidovudine dosage: . During the same period patient was treated with LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ).

6797299-3 | Adrenal Insufficiency, Dehydration, Haemoptysis, Hypotension, Immune Reconstitution Syndrome, Lung Infiltration, Pulmonary Tuberculosis, Pyrexia, Respiratory Failure
Patient was taking Zidovudine (View Usage). After Zidovudine was administered, patient had the following side effects: adrenal insufficiency, dehydration, haemoptysis, hypotension, immune reconstitution syndrome, lung infiltration, pulmonary tuberculosis, pyrexia, respiratory failure on Jun 08, 2010 from COLOMBIA Additional patient health information: Male patient , 47 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Zidovudine dosage: . During the same period patient was treated with LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), ISONIAZID (View Isoniazid Review and Isoniazid Label ), RIFAMPICIN (View Rifampicin Review and Rifampicin Label ), PYRAZINAMIDE (View Pyrazinamide Review and Pyrazinamide Label ), ETHAMBUTOL HYDROCHLORIDE (View Ethambutol Hydrochloride Review and Ethambutol Hydrochloride Label ). Patient was hospitalized.

6774129-7 | Immune Reconstitution Syndrome, Visceral Leishmaniasis
Adverse event was reported on Jun 03, 2010 by a Male patient taking Zidovudine (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: AUSTRALIA , 60 years of age, Patient experienced the following unwanted or unexpected effects: immune reconstitution syndrome, visceral leishmaniasis. During the same period patient was treated with LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), LOPINAVIR/RITONAVIR (View Lopinavir/ritonavir Review and Lopinavir/ritonavir Label ), TENOFOVIR DISOPROXIL FUMARATE (View Tenofovir Disoproxil Fumarate Review and Tenofovir Disoproxil Fumarate Label ), COTRIM (View Cotrim Review and Cotrim Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), ABACAVIR (View Abacavir Review and Abacavir Label ).

6771644-7 | Cytomegalovirus Chorioretinitis, Lung Disorder, Retinal Detachment, Retinal Tear, Uveitis, Vasculitis, Vitreous Floaters
on Jun 01, 2010 Female patient from TURKEY , 36 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Zidovudine (View Usage). Patient had the following side effects: cytomegalovirus chorioretinitis, lung disorder, retinal detachment, retinal tear, uveitis, vasculitis (What is vasculitis?), vitreous floaters. Zidovudine dosage: . During the same period patient was treated with STAVUDINE (View Stavudine Review and Stavudine Label ), DIDANOSINE (View Didanosine Review and Didanosine Label ), NELFINAVIR MESYLATE (View Nelfinavir Mesylate Review and Nelfinavir Mesylate Label ), GANCICLOVIR (View Ganciclovir Review and Ganciclovir Label ).

6770882-7 | Aids Encephalopathy, Cognitive Disorder, Confusional State, Mobility Decreased
on May 28, 2010 Male patient from , 55 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Zidovudine (View Usage). After Zidovudine was administered, patient had the following side effects: aids encephalopathy, cognitive disorder, confusional state, mobility decreased. Zidovudine dosage: . During the same period patient was treated with ABACAVIR (View Abacavir Review and Abacavir Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), LOPINAVIR (View Lopinavir Review and Lopinavir Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ). Patient was hospitalized.

6768056-9 | Abdominal Pain Upper, Anaemia, Enzyme Abnormality, Lipase Abnormal, Pancreatitis Acute
Patient was taking Zidovudine (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper, anaemia, enzyme abnormality, lipase abnormal, pancreatitis acute on Jun 02, 2010 from SPAIN Additional patient health information: Male patient , 48 years of age, . Zidovudine dosage: . During the same period patient was treated with ABACAVIR (View Abacavir Review and Abacavir Label ), LAMIVUDINE HIV (View Lamivudine-hiv Review and Lamivudine-hiv Label ), LOPINAVIR/RITONAVIR (View Lopinavir/ritonavir Review and Lopinavir/ritonavir Label ), DIDANOSINE (View Didanosine Review and Didanosine Label ). Patient was hospitalized.

6759108-8 | Gastrointestinal Hypomotility, Hyperglycaemia, Ileal Perforation, Infantile Apnoeic Attack, Metabolic Acidosis, Necrotising Enterocolitis Neonatal, Neonatal Respiratory Distress Syndrome, Premature Baby
Adverse event was reported on Jun 02, 2010 by a Male patient taking Zidovudine (View Usage) (Dosage: ) was diagnosed with prophylaxis, neonatal respiratory distress syndrome, pathogen resistance and. Location: , weighting 2.20 lb, Patient had the following side effects: gastrointestinal hypomotility, hyperglycaemia, ileal perforation, infantile apnoeic attack, metabolic acidosis, necrotising enterocolitis neonatal, neonatal respiratory distress syndrome, premature baby. During the same period patient was treated with CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), CUROSURF (View Curosurf Review and Curosurf Label ), AMPICILLIN AND SULBACTAM (View Ampicillin And Sulbactam Review and Ampicillin And Sulbactam Label ), AMIKACIN (View Amikacin Review and Amikacin Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ). Patient was hospitalized.

6744199-0 | Congenital Inguinal Hernia
on May 10, 2010 Female patient from , weighting 7.32 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Zidovudine (View Usage). After Zidovudine was administered, patient had the following side effects: congenital inguinal hernia. Zidovudine dosage: Transplacent. During the same period patient was treated with NEFINAVIR (Transplacent) (View Nefinavir Review and Nefinavir Label ), LAMIVUDINE (Transplacent) (View Lamivudine Review and Lamivudine Label ).

6743747-4 | Intra-abdominal Haemangioma, Premature Baby, Teratoma
on Mar 29, 2010 Male patient from European Union , weighting 6.97 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Zidovudine (View Usage). Patient experienced the following unwanted or unexpected effects: intra-abdominal haemangioma, premature baby, teratoma. Zidovudine dosage: Transplacent. During the same period patient was treated with NELFINAVIR (Transplacent) (View Nelfinavir Review and Nelfinavir Label ), LAMIVUDINE (Transplacental) (View Lamivudine Review and Lamivudine Label ).

6743273-2 | Cytomegalovirus Chorioretinitis, Hypopyon, Uveitis
Patient was taking Zidovudine (View Usage). Patient had the following side effects: cytomegalovirus chorioretinitis, hypopyon, uveitis on May 24, 2010 from Additional patient health information: Male patient , 60 years of age, was diagnosed with acquired immunodeficiency syndrome and. Zidovudine dosage: . During the same period patient was treated with EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ).

6738299-9 | Anaemia, Aplasia Pure Red Cell, Bedridden, Blood Osmolarity Decreased, Blood Parathyroid Hormone Decreased, Cachexia, Cardiovascular Disorder, Cholestasis, Condition Aggravated
Adverse event was reported on May 14, 2010 by a Male patient taking Zidovudine (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: AUSTRALIA , 60 years of age, After Zidovudine was administered, patient had the following side effects: anaemia, aplasia pure red cell, bedridden, blood osmolarity decreased, blood parathyroid hormone decreased, cachexia, cardiovascular disorder, cholestasis, condition aggravated. During the same period patient was treated with LAMIVUDINE HIV (View Lamivudine-hiv Review and Lamivudine-hiv Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), LOPINAVIR (View Lopinavir Review and Lopinavir Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), TENOFOVIR (View Tenofovir Review and Tenofovir Label ). Patient was hospitalized.

6730569-3 | Aortic Valve Sclerosis, Caesarean Section, Cardiac Murmur, Congenital Anomaly, Congenital Heart Valve Disorder, Large For Dates Baby, Pulmonary Valve Sclerosis, Respiratory Arrest
on Apr 29, 2010 Female patient from , weighting 7.52 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Zidovudine (View Usage). Patient experienced the following unwanted or unexpected effects: aortic valve sclerosis, caesarean section, cardiac murmur, congenital anomaly, congenital heart valve disorder, large for dates baby, pulmonary valve sclerosis, respiratory arrest. Zidovudine dosage: Transplacental. During the same period patient was treated with DARUNAVIR (600mg, Bid, Transplacent) (View Darunavir Review and Darunavir Label ), ISENTRESS (400mg, Bid, Transplacental) (View Isentress Review and Isentress Label ), RITONAVIR (Transplacental) (View Ritonavir Review and Ritonavir Label ), TRUVADA (Transplacental) (View Truvada Review and Truvada Label ).

6728515-1 | Abdominal Distension, Abdominal Hernia, Cardiac Murmur, Congenital Anomaly, Cryptorchism
on May 10, 2010 Male patient from UNITED KINGDOM , weighting 7.43 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Zidovudine (View Usage). Patient had the following side effects: abdominal distension, abdominal hernia, cardiac murmur, congenital anomaly, cryptorchism. Zidovudine dosage: 600 Mg, 1x/day. During the same period patient was treated with VIRACEPT (2500 Mg, 1x/day) (View Viracept Review and Viracept Label ), LAMIVUDINE (1200 Mg, 1x/day) (View Lamivudine Review and Lamivudine Label ), KALETRA (600 Mg, 1x/day) (View Kaletra Review and Kaletra Label ), VIREAD (300 Mg, 1x/day) (View Viread Review and Viread Label ), COMBIVIR (600 Mg, 1x/day) (View Combivir Review and Combivir Label ), RETROVIR (600 Mg, 1x/day) (View Retrovir Review and Retrovir Label ), CRIXIVAN (Unk) (View Crixivan Review and Crixivan Label ), TRUVADA (Unk) (View Truvada Review and Truvada Label ).

6713640-1 | Apnoea, Cardiac Murmur, Congenital Heart Valve Disorder, Ventricular Hypertrophy
Patient was taking Zidovudine (View Usage). After Zidovudine was administered, patient had the following side effects: apnoea, cardiac murmur, congenital heart valve disorder, ventricular hypertrophy on Apr 29, 2010 from UNITED KINGDOM Additional patient health information: Female patient , weighting 7.52 lb, . Zidovudine dosage: . During the same period patient was treated with RITONAVIR (View Ritonavir Review and Ritonavir Label ), ISENTRESS (800mg Per Day) (View Isentress Review and Isentress Label ), DARUNAVIR (1200mg Per Day) (View Darunavir Review and Darunavir Label ), TRUVADA (View Truvada Review and Truvada Label ).

6701415-9 | Osteonecrosis
Adverse event was reported on Apr 15, 2010 by a Male patient taking Zidovudine (View Usage) (Dosage: Unk) was diagnosed with hiv infection (What is hiv infection?) and. Location: COTE D'IVOIRE , 33 years of age, weighting 149.9 lb, Patient experienced the following unwanted or unexpected effects: osteonecrosis (What is osteonecrosis?). During the same period patient was treated with DIDANOSINE (Unk) (View Didanosine Review and Didanosine Label ), SAQUINAVIR (Unk) (View Saquinavir Review and Saquinavir Label ), STAVUDINE (Unk) (View Stavudine Review and Stavudine Label ), LAMIVUDINE (Unk) (View Lamivudine Review and Lamivudine Label ), NELFINAVIR MESYLATE (Unk) (View Nelfinavir Mesylate Review and Nelfinavir Mesylate Label ), EFAVIRENZ (Unk) (View Efavirenz Review and Efavirenz Label ). Patient was hospitalized.

6701208-2 | Caesarean Section, Cardiac Murmur, Congenital Heart Valve Disorder, Congenital Pulmonary Valve Disorder, Neonatal Respiratory Arrest, Ventricular Hypertrophy
on Apr 12, 2010 Female patient from UNITED KINGDOM , weighting 7.52 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Zidovudine (View Usage). Patient had the following side effects: caesarean section, cardiac murmur, congenital heart valve disorder, congenital pulmonary valve disorder, neonatal respiratory arrest, ventricular hypertrophy. Zidovudine dosage: Transplacental. During the same period patient was treated with DARUNAVIR (600mg, Bid; Transplacent) (View Darunavir Review and Darunavir Label ), ISENTRESS (400mg, Bid; Transplacental) (View Isentress Review and Isentress Label ), RITONAVIR (Transplacental) (View Ritonavir Review and Ritonavir Label ).

6682982-0 | Caesarean Section
on Mar 29, 2010 Male patient from , weighting 7.05 lb, was diagnosed with hiv infection (What is hiv infection?), antiviral prophylaxis and was treated with Zidovudine (View Usage). After Zidovudine was administered, patient had the following side effects: caesarean section. Zidovudine dosage: Transplacent. During the same period patient was treated with NEVIRAPINE (Transplacent; 3 Weeks (3 Trimester)) (View Nevirapine Review and Nevirapine Label ), COMBIVIR (Transplacent) (View Combivir Review and Combivir Label ), KALETRA (Transplacent) (View Kaletra Review and Kaletra Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), SEPTRIN (View Septrin Review and Septrin Label ), VIRAMUNE (Transplacental ) (View Viramune Review and Viramune Label ).

6679670-3 | Apnoea, Cardiac Murmur, Congenital Heart Valve Disorder
Patient was taking Zidovudine (View Usage). Patient experienced the following unwanted or unexpected effects: apnoea, cardiac murmur, congenital heart valve disorder on Apr 07, 2010 from UNITED KINGDOM Additional patient health information: Female patient , weighting 7.52 lb, . Zidovudine dosage: . During the same period patient was treated with RITONAVIR (View Ritonavir Review and Ritonavir Label ), ISENTRESS (800mg Per Day) (View Isentress Review and Isentress Label ), DARUNAVIR (1200mg Per Day) (View Darunavir Review and Darunavir Label ).

6677468-3 | Abdominal Pain, Amnesia, Diarrhoea, Flatulence, Gait Disturbance, Pancytopenia, Pneumothorax, Pyrexia, Sepsis
Adverse event was reported on Apr 07, 2010 by a Male patient taking Zidovudine (View Usage) (Dosage: 300mg Per Day) was diagnosed with hiv infection (What is hiv infection?) and. Location: BRAZIL , 44 years of age, weighting 123.5 lb, Patient had the following side effects: abdominal pain (What is abdominal pain?), amnesia, diarrhoea, flatulence, gait disturbance, pancytopenia, pneumothorax, pyrexia, sepsis (What is sepsis?). During the same period patient was treated with MARAVIROC (150mg Twice Per Day) (View Maraviroc Review and Maraviroc Label ), DARUNAVIR (View Darunavir Review and Darunavir Label ), TENOFOVIR (View Tenofovir Review and Tenofovir Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), DAPSONE (View Dapsone Review and Dapsone Label ), FOLINIC ACID (View Folinic Acid Review and Folinic Acid Label ), PYRIMETHAMINE TAB (View Pyrimethamine Tab Review and Pyrimethamine Tab Label ), LAMOTRIGINE (View Lamotrigine Review and Lamotrigine Label ). Patient was hospitalized.

6674098-4 |
on Mar 26, 2010 Male patient from UNITED KINGDOM , weighting 7.05 lb, was diagnosed with antiviral prophylaxis, hiv infection (What is hiv infection?) and was treated with Zidovudine (View Usage). . Zidovudine dosage: Unk. During the same period patient was treated with LAMIVUDINE (Unk) (View Lamivudine Review and Lamivudine Label ), NEVIRAPINE (Unk) (View Nevirapine Review and Nevirapine Label ), COMBIVIR (Unk) (View Combivir Review and Combivir Label ), KALETRA (Unk) (View Kaletra Review and Kaletra Label ), SEPTRIN (Unk) (View Septrin Review and Septrin Label ), VIRAMUNE (Unk) (View Viramune Review and Viramune Label ).

6671398-9 | Haematochezia
on Mar 29, 2010 Male patient from GERMANY , weighting 5.07 lb, was treated with Zidovudine (View Usage). Patient experienced the following unwanted or unexpected effects: haematochezia. Zidovudine dosage: 14mg Per Day.

6669790-1 | Congenital Anomaly, Hepatic Cyst, Sickle Cell Anaemia, Splenomegaly
Patient was taking Zidovudine (View Usage). Patient had the following side effects: congenital anomaly, hepatic cyst, sickle cell anaemia, splenomegaly on Apr 02, 2010 from THAILAND Additional patient health information: Male patient , weighting 7.10 lb, was diagnosed with hiv infection (What is hiv infection?) and. Zidovudine dosage: Transplacent. During the same period patient was treated with NELFINAVIR MESYLATE (Transplacent) (View Nelfinavir Mesylate Review and Nelfinavir Mesylate Label ), LAMIVUDINE (Transplacental) (View Lamivudine Review and Lamivudine Label ), RITONAVIR (Transplacental) (View Ritonavir Review and Ritonavir Label ), EFAVIRENZ (Transplacental) (View Efavirenz Review and Efavirenz Label ), LOPINAVIR (Transplacental) (View Lopinavir Review and Lopinavir Label ).